The cofounder and chief executive officer of Kate Therapeutics discussed research that awarded him an Outstanding New Investigator at the ASGCT 2024 meeting.
Sharif Tabebordbar, PhD
Advertisement
Articles by Sharif Tabebordbar, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
